Beijing Tiantan Biological Hits Day High with 3.67% Surge Amid Market Decline

Beijing Tiantan Biological Products Corp. has experienced a notable increase of 3.67% on May 29, 2026, reaching an intraday high of CNY 13.74. This performance stands in contrast to the China Shanghai Composite, which declined by 0.73% on the same day. Over the past week, the stock has shown a positive trend, gaining 2.26%, while the broader index fell by 1.08%. Despite this day's performance, the stock has faced significant challenges over longer periods. In the past month, it has decreased by 6.23%, and over the last year, it has dropped by 29.54%. Year-to-date, the stock is down 17.07%, and its three-year performance reflects a decline of 50.67%. Financial metrics indicate that the company has struggled with net sales, which fell by 24.69% in its latest results. The operating cash flow is reported at CNY -324.97 million, and the return on capital employed is at a low of 11.91%. With a market capitalization of CNY 27,248 million, Beijing Tiantan continues to navigate a challenging landscape in the pharmaceuticals and biotechnology sector.